Long-term study of people with obesity and a comparison group
Follows adults with obesity and a control group through yearly checkups.
Plain-language title generated from the registry record
Registry title: Nutriomics and Artificial Intelligence Nutrition Obesity Cohort
Key facts
- Where
- Seoul, South KoreaSee the site
Where in South Korea
- Yonsei University Health System, Severance HospitalSeoul, South KoreaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Yonsei University
- Trial code
- NCT05494138
- Record updated
- 9 August 2022
- Original description
The purpose of this study is to establish a prospective cohort. From registration to the 5th year, basic investigation, specific examinations for cardiovascular and metabolic disease, basic blood tests, collection of human material samples, and clinical event follow-up are conducted yearly. The obese group will be examined yearly, and telephone follow-up will be conducted if necessary. The control group will participate in the baseline survey once enrollment and clinical event follow-up by phone will be conducted annually thereafter. From the 6th year, only clinical event follow-up will be conducted.Read full original descriptionShow less
Nutriomics and Artificial Intelligence Nutrition Obesity Cohort
The purpose of this study is to establish a prospective cohort. From registration to the 5th year, basic investigation, specific examinations for cardiovascular and metabolic disease, basic blood tests, collection of human material samples, and clinical event follow-up are conducted yearly. The obese group will be examined yearly, and telephone follow-up will be conducted if necessary. The control group will participate in the baseline survey once enrollment and clinical event follow-up by phone will be conducted annually thereafter. From the 6th year, only clinical event follow-up will be conducted.
Inclusion: Adults 19 years of age or older; Obese patients with chronic diseases such as cardiovascular disease, hypertension, diabetes, and metabolic syndrome (BMI ≥ 25 kg/m2, [BMI ≥ 30 kg/m2, including 10% or more]); Adults 19 years of age or older; Those with BMI 18.5~24.9 kg/m2.
Exclusion: Patients within 3 months of organ transplantation; Patients currently being treated for acute transplant rejection; Patients taking steroids, female hormones; Serious non-cardiovascular disease with life expectancy less than 6 months; Patients treated for acute coronary syndrome (myocardial infarction, unstable angina) and discharged within 6 months; Type 1 Diabetes; Serious non-cardiovascular disease with life expectancy less than 6 months; Persons who are continuously taking medications prescribed by a doctor due to chronic diseases excluding hypertension and dyslipidemia; Within 5 years of diagnosis of malignant tumor; Pregnant or suspected of being pregnant or are lactating; Patients with acute cerebral infarction within 6 months of being hospitalized and discharged; Those who have difficulty using smartphones; Pregnant or suspected of being pregnant or are lactating; Those who have difficulty using smartphones.